Dimensional Fund Advisors LP raised its position in Stoke Therapeutics, Inc. (NASDAQ:STOK – Free Report) by 19.7% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 989,936 shares of the company’s stock after buying an additional 162,797 shares during [...]